Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its insiders. Intellia Therapeutics Inc shares valued at $2,252 were sold by Bhanji Muna on Apr 29 ’25. At $8.50 per share, Bhanji Muna sold 265 shares. The insider’s holdings dropped to 19,203 shares worth approximately $0.16 million following the completion of this transaction.
Also, Clark Eliana sold 679 shares, netting a total of over 6,104 in proceeds. Following the sale of shares at $8.99 each, the insider now holds 95,369 shares.
Before that, BASTA JAMES had sold 2,572 shares from its account. In a trade valued at $23,122, the EVP, General Counsel traded Intellia Therapeutics Inc shares for $8.99 each. Upon closing the transaction, the insider’s holdings decreased to 2,572 shares, worth approximately $0.93 million.
As published in a research note from Wolfe Research on April 21, 2025, Intellia Therapeutics Inc [NTLA] has been rated up from a Peer perform to an Outperform and the price target has been revised to $21. Analysts at H.C. Wainwright started covering the stock with ‘”a Buy”‘ outlook in a report released in early March. As of February 28, 2025, JP Morgan has decreased its “an Overweight” rating to a “Neutral” for NTLA. Earlier on February 28, 2025, Goldman downgraded its rating. Their new recommendation was “a Sell” for NTLA stock which previously was a “a Neutral”.
Analyzing NTLA Stock Performance
On last trading session,, Intellia Therapeutics Inc [NASDAQ: NTLA] plunged -0.24% to $8.35. The stock’s lowest price that day was $8.06, but it reached a high of $8.445 in the same session. During the last five days, there has been a surge of approximately 10.16%. Over the course of the year, Intellia Therapeutics Inc shares have dropped approximately -28.39%.
Support And Resistance Levels for Intellia Therapeutics Inc (NTLA)
RSI (Relative Strength Index) is 51.19 on the 14-day chart, showing neutral technical sentiment.
Is Intellia Therapeutics Inc subject to short interest?
Stocks of Intellia Therapeutics Inc saw a sharp rise in short interest on 2025-05-30 jumping by 2.81 million shares to 31.56 million. Data from Yahoo Finance shows that the short interest on 2025-04-30 was 28.75 million shares. A jump of 8.9% in short interest reflects a negative sentiment towards the stock. Despite the fact that short shares comprise just 6.56 of the overall float, the days-to-cover ratio (short ratio) jumped to 6.56.
